Mainz Biomed N.V. Ordinary Shares (MYNZ) is a publicly traded Healthcare sector company. As of May 21, 2026, MYNZ trades at $0.84 with a market cap of $10.56M and a P/E ratio of -0.50. MYNZ moved +5.07% today. Year to date, MYNZ is -47.57%; over the trailing twelve months it is -81.89%. Its 52-week range spans $0.55 to $16.04. Analyst consensus is hold with an average price target of $0.00. Rallies surfaces MYNZ's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Hedge funds tracked by Rallies that own MYNZ include Citadel Advisors. The latest tracked quarter is Mar 31, 2024. Rallies shows current holdings, share counts, position changes, and 13F ownership context for Mainz Biomed N.V. Ordinary Shares.
| Metric | Value |
|---|---|
| Price | $0.84 |
| Market Cap | $10.56M |
| P/E Ratio | -0.50 |
| EPS | $-1.67 |
| Dividend Yield | 0.00% |
| 52-Week High | $16.04 |
| 52-Week Low | $0.55 |
| Volume | 5.25M |
| Avg Volume | 0 |
| Revenue (TTM) | $537.08K |
| Net Income | $-16.29M |
| Gross Margin | 0.00% |
3 analysts cover MYNZ: 0 strong buy, 1 buy, 2 hold, 0 sell, 0 strong sell. Consensus rating is hold. Average price target: $0.00.